Stay updated on Early Ixekizumab Activity in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Early Ixekizumab Activity in Psoriasis Clinical Trial page.

Latest updates to the Early Ixekizumab Activity in Psoriasis Clinical Trial page
- Check6 days agoChange DetectedThe footer now identifies the site revision as v3.8.0 instead of v3.7.2. The study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedA site-wide NIH banner announces updates about website terminology, stating that “Super Intelligence” is being used in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe site footer now shows revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now shows a 403 Forbidden error with only the header and footer visible; the detailed study content and related resources are no longer shown.SummaryDifference17%

- Check69 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5 tag, indicating a new release of the page's underlying framework.SummaryDifference0.1%

Stay in the know with updates to Early Ixekizumab Activity in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Ixekizumab Activity in Psoriasis Clinical Trial page.